Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Institute on Drug Abuse (NIDA) |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00000340 |
The purpose of this study is to assess the efficacy of pemoline in treating cocaine and/or methamphetamine dependent adults with comorbid Adult Attention Deficit Hyperactivity Disorder (ADHD).
Condition | Intervention | Phase |
---|---|---|
Cocaine-Related Disorders |
Drug: Pemoline |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment |
Official Title: | Pemoline in the Treatment of Stimulant Dependence |
Ages Eligible for Study: | 21 Years to 50 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
M/F ages 21-50. Meet DSM-IV criteria for cocaine dependence. Agree to conditions of the study and sign informed consent.
Exclusion Criteria:
Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics. Acute hepatitis. Other medical condtions that deem participation to be unsafe.
Study ID Numbers: | NIDA-3-0010-5, Y01-3-0010-5 |
Study First Received: | September 20, 1999 |
Last Updated: | August 25, 2008 |
ClinicalTrials.gov Identifier: | NCT00000340 |
Health Authority: | United States: Federal Government |
Cocaine-Related Disorders Pemoline Mental Disorders Substance-Related Disorders Disorders of Environmental Origin |
Therapeutic Uses Physiological Effects of Drugs Central Nervous System Stimulants Central Nervous System Agents Pharmacologic Actions |